Xinjiang Xuefeng Sci-Tech(Group)Co.,Ltd (603227.SS)
Urumqi, CN
Xinjiang Xuefeng Sci-Tech (Group) Co., Ltd. is dedicated to the development, manufacturing, and commercialization of explosives intended for civilian uses. The company's product offerings are comprehensive, featuring various explosives such as expanded ammonium nitrate, emulsion, and on-site mixed formulations. It also produces a range of detonators, including industrial electric, digital electronic, and plastic types, in addition to industrial detonating cords and associated cables. Beyond its product line, Xinjiang Xuefeng provides extensive engineering blasting services, which include drilling, demolition, excavation, and material transport. Furthermore, it offers expert professional services, covering strategic solution planning and execution. The company is also involved in international trade through its export operations. Established in 1958, Xinjiang Xuefeng Sci-Tech (Group) Co., Ltd. is based in Ürümqi, People's Republic of China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.56% | +4.17% | +1.51% | -1.69% | +2.10% | +5.05% | -2.67% | +3.07% | +77.28% | +4.17% | +143.45% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-8.8% Q1'26: -6.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-24.6% Q1'26: -29.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+3.5% Q1'26: -9.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+12.6% ★ Q1'26: +7.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+8.9% ★ Q1'26: +3.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: -0.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.13× Q1'26: 3.46× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|
| Revenue |
6.90B
est: 1.23B (+459.4%)
|
7.02B
est: 7.64B (-8.1%)
|
6.10B
est: 8.14B (-25.1%)
|
5.56B
est: 5.97B (-6.7%)
|
6.71B
6.71B – 6.71B
+12.5% YoY
|
7.67B
7.67B – 7.67B
+14.4% YoY
|
| EBITDA |
1.89B
est: 286.74M (+558.2%)
|
1.49B
est: 1.78B (-16.1%)
|
1.28B
est: 1.94B (-33.9%)
|
1.09B
est: 1.42B (-23.2%)
|
1.60B
1.60B – 1.60B
+12.5% YoY
|
1.83B
1.83B – 1.83B
+14.4% YoY
|
| EBIT |
1.53B
est: 217.35M (+602.3%)
|
1.14B
est: 1.35B (-15.1%)
|
912.82M
est: 1.46B (-37.5%)
|
700.21M
est: 1.07B (-34.5%)
|
1.20B
1.20B – 1.20B
+12.5% YoY
|
1.38B
1.38B – 1.38B
+14.4% YoY
|
| Net Income |
665.83M
est: 187.55M (+255.0%)
|
853.53M
est: 846.64M (+0.8%)
|
668.43M
est: 878.75M (-23.9%)
|
503.67M
est: 557.25M (-9.6%)
|
739.43M
739.43M – 739.43M
+32.7% YoY
|
900.18M
900.18M – 900.18M
+21.7% YoY
|
| SGA |
376.80M
est: 80.29M (+369.3%)
|
388.07M
est: 497.22M (-22.0%)
|
422.23M
est: 416.03M (+1.5%)
|
88.87M
est: 304.72M (-70.8%)
|
342.68M
342.68M – 342.68M
+12.5% YoY
|
391.97M
391.97M – 391.97M
+14.4% YoY
|
| EPS |
0.81
est: 0.18 (+362.9%)
|
0.82
est: 0.79 (+3.8%)
|
0.62
est: 0.82 (-23.9%)
|
0.47
est: 0.52 (-9.6%)
|
0.69
0.69 – 0.69
+32.7% YoY
|
0.84
0.84 – 0.84
+21.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 227.8K | 0.39% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 49.2K | 0.46% |
| 3 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 342.2K | 0.06% |
| 4 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 11.3K | 0.44% |
| 5 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 135.1K | 0.29% |
| 6 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 27.5K | 0.26% |
| 7 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 12.2K | 0.48% |
| 8 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 103.2K | 0.28% |
| 9 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 1.36M | 0.06% |
| 10 | Vanguard ESG International Stock ETF VSGX | 0.00% | 19.2K | 0.10% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dasong Zhang | Executive Vice President | — | male |
| Li Zhu Feng | Deputy General Manager | — | male |
| Xi Chen | Company Secretary | — | male |
| Xin Wang | Deputy General Manager | — | female |
| Yan Yan Hu | Deputy GM & Chief Financial Officer | — | female |
| Yong Tian | GM & Director | — | male |
| Zhong Zhang | Executive Vice President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603227.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
